| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910449834903321 |
|
|
Titolo |
Atherosclerosis and autoimmunity [[electronic resource] /] / editors, Yehuda Shoenfeld, Dror Harats, George Wick |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Amsterdam ; ; New York, : Elsevier, 2001 |
|
|
|
|
|
|
|
ISBN |
|
1-281-05970-6 |
9786611059705 |
0-08-052765-5 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (395 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
ShoenfeldYehuda |
HaratsDror |
WickG (Georg) |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Atherosclerosis - Immunological aspects |
Autoimmunity |
Atherosclerosis - Pathogenesis |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
"Section V: Anti-endothelial cell antibodies and atherosclerosis / edited by Pierre Youinou and Pier-Lugi Meroni." |
|
|
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Front Cover; Atherosclerosis and Autoimmunity; Copyright Page; Contents; Preface; List of Contributors; Introduction: Autoimmunity as an Additional 'Risk Factor' for Artherosclerosis; Part I: Autoimmunity and Atherosclerosis; Chapter 1. The Autoimmune Pathogenesis of Atherosclerosis - an Evolutionary-Darwinian Concept; Chapter 2. Autoimmune Aspects of Atherosclerosis; Part II: Pathogenetic Immune Mechanism of Atherosclerosis; Chapter 3. The Role of Macrophage Scavenger Receptors in Atherogenesis |
Chapter 4. CD36, the Macrophage Class B Scavenger Receptor: Regulation and Role in AtherosclerosisChapter 5. Atherosclerosis, Matrix-Metalloproteinases (MMPs) and Ischemia/Hypoxia; Chapter 6. Ceramide Pathway and Apoptosis in Autoimmunity and Atherosclerosis; Chapter 7. a a-Defensins: Potential Link between Inflammation, Thrombosis and Atherosclerosis; Chapter 8. Lipids and Immunity; Part III: Infections, Immunity and Atherosclerosis; Chapter 9. Immune |
|
|
|
|
|
|
|
|
|
|
|
Activation Augments Infection-Dependent Atherogenesis |
Chapter 10. Host Response Differences to Infection May Affect Disease Susceptibility in Atherosclerotic PatientsChapter 11. The Role of Chronic Infection in Atherosclerosis; Part IV: Atherosclerosis Related Autoantibodies; Chapter 12. Atherosclerosis: Evidence for the Role of Autoimmunity; Chapter 13. Oxidized Autoantigens in Atherosclerosis; Chapter 14. Autoantibodies against Oxidized Palmitoyl Arachidonoyl Phosphocholine in Atherosclerosis; Chapter 15. Autoantibodies to Endothelial Cells and Oxidized LDL in Human Atherosclerosis and Hypertension |
Chapter 16. Technical and Clinical Aspects about Autoantibody Assays for Oxidized Low Density LipoproteinChapter 17. Is There a Role for Paraoxonase in Atherosclerosis and in Antiphospholipid Syndrome?; Chapter 18. Anti-Prothrombin Antibodies in Thrombosis and Atherosclerosis; Chapter 19. Detection of Cellular Activity in Atherosclerosis by the Novel Cellscan System; Part V: Anti-Endothelial Cell Antibodies (AECA) and Atherosclerosis Section Editors: Pierre Youinou and Pier-Luigi Meroni; Chapter 20. Pathogenicity of Antiendothelial Cell Autoantibodies |
Chapter 21. Functional Heterogeneity of Pathogenic Anti-Endothelial Cell AntibodiesChapter 22. The Aspect of Anti-Proteinase 3 Antibodies as AECA; Chapter 23. Anti-Endothelial Cell Antibodies (AECA) in Systemic Lupus Erythematosus: Clinical Relevance; Chapter 24. Endothelial Cell Dysfunction in Atherosclerosis and Autoimmunity; Chapter 25. Modulation of Endothelial Cell Function by Normal Poly specific Human Immunoglobulins (IVIg); Part VI: Accelerated Atherosclerosis in Disease; Chapter 26. Cardiovascular Morbidity in the Hopkins Lupus Cohort |
Chapter 27. Atherosclerosis in Systemic Lupus Erythematosus: Clinical Relevance |
|
|
|
|
|
|
Sommario/riassunto |
|
Presenting further studies in the prevention and treatment of coronary artery disease, this book brings together the knowledge accrued in the past decade concerning the role of immunity in the initiation and perpetuation of atherosclerosis. A strong group of international contributors summarize the diverse aspects of the interrelationship between the immune system and atherosclerosis. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910227344903321 |
|
|
Autore |
Karen L. Beemon (Ed.) |
|
|
Titolo |
Viral Interactions with Host RNA Decay Pathways |
|
|
|
|
|
Pubbl/distr/stampa |
|
|
MDPI - Multidisciplinary Digital Publishing Institute, 2017 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (VIII, 98 p.) |
|
|
|
|
|
|
Soggetti |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Sommario/riassunto |
|
Eukaryotes have evolved a wide variety of RNA decay pathways to maintain cellular homeostasis, carry out programs of gene expression, and respond to changing environmental conditions. Individual RNA turnover mechanisms can operate constitutively or under only particular cellular conditions; similarly, some target many RNAs, while others act with great specificity. It has become increasingly clear that there are extensive interactions between viruses and the host RNA decay machinery. Often, the cellular RNA decay machinery poses a threat to viral gene expression, but viruses can also manipulate RNA decay pathways to promote viral replication. This special issue focuses on how cellular RNA decay factors recognize and degrade viral RNAs and viral strategies to subvert or evade these pathways. |
|
|
|
|
|
|
|
| |